Week 48 Resistance Analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 Infected Women (WAVES Study GS-US-236-0128)

BACKGROUND: Women and those with non-B subtype HIV-1 are typically underrepresented in clinical trials. WAVES (GS-US-236-0128) was a double-blind phase 3b study among treatment-naïve HIV-1-infected women that demonstrated that elvitegravir/cobicistat/emtricitabine/tenofovir DF (EVG/COBI/FTC/TDF; N=2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:HIV Clin Trials
Main Authors: Kulkarni, Rima, Hodder, Sally L., Cao, Huyen, Chang, Silvia, Miller, Michael D., White, Kirsten L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5942200/
https://ncbi.nlm.nih.gov/pubmed/28891788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15284336.2017.1370059
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados